Mesenchymal Stem Cells Induce T-Cell Tolerance and Protect the Preterm Brain after Global Hypoxia-Ischemia-Reference-Cited by-同舟云学术

Mesenchymal Stem Cells Induce T-Cell Tolerance and Protect the Preterm Brain after Global Hypoxia-Ischemia

Published:2013-08-26 Issue:8 Volume:8 Page:e73031
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Jellema Reint K.,Wolfs Tim G. A. M.,Lima Passos Valéria,Zwanenburg Alex,Ophelders Daan R. M. G.,Kuypers Elke,Hopman Anton H. N.,Dudink Jeroen,Steinbusch Harry W.,Andriessen Peter,Germeraad Wilfred T. V.,Vanderlocht Joris,Kramer Boris W.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference54 articles.

1. Late oligodendrocyte progenitors coincide with the developmental window of vulnerability for human perinatal white matter injury;SA Back;J Neurosci,2001

2. The developing oligodendrocyte: key cellular target in brain injury in the premature infant;JJ Volpe;Int J Dev Neurosci,2011

3. Neurology of the Newborn;JJ Volpe,2008

4. Arrested preoligodendrocyte maturation contributes to myelination failure in premature infants;JR Buser;Ann Neurol,2012

5. Brain injury in premature infants: a complex amalgam of destructive and developmental disturbances;JJ Volpe;Lancet Neurol,2009

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of Microglial Modulation in Therapies for Perinatal Brain Injuries Leading to Neurodevelopmental Disorders;Advances in Neurobiology;2024

2. Mononuclear cell therapy of neonatal hypoxic‐ischemic encephalopathy in preclinical versus clinical studies: A systematic analysis of therapeutic efficacy and study design;Neuroprotection;2023-12

3. A Pilot Phase I Trial of Allogeneic Umbilical Cord Tissue-Derived Mesenchymal Stromal Cells in Neonates With Hypoxic-Ischemic Encephalopathy;Stem Cells Translational Medicine;2023-06-01

4. Extracellular vesicles from immortalized mesenchymal stromal cells protect against neonatal hypoxic-ischemic brain injury;Inflammation and Regeneration;2023-04-17

5. Harnessing the therapeutic potential of the stem cell secretome in neonatal diseases;Seminars in Perinatology;2023-04